Transthyretin Amyloid Cardiomyopathy (ATTR-CM) cardiogenomics: a tertiary centre experience

Back

ESC2025 Premium Access

Transthyretin Amyloid Cardiomyopathy (ATTR-CM) cardiogenomics: a tertiary centre experience

Session: Shedding light on transthyretin cardiac amyloidosis

Topic: Infiltrative Myocardial Disease

Speaker: Doctor R. Amador (Lisbon, PT)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Rita Amador

Hospital Santa Cruz, Lisbon (Portugal)

1 presentation

0 follower

7 more presentations in this session

Predictors and outcomes of amyloid cardiomyopathy caused by transthyretin V30 mutation

Speaker: Doctor M. Pereira Santos (Porto, PT)

Nutritional status and its impact on transthyretin cardiac amyloidosis: unraveling connection

Speaker: Mrs P. Lujan Garcia (Las Palmas de Gran Canaria, ES)

Plasma transthyretin fractions in transthyretin cardiac amyloidosis patients undergoing tafamidis treatment

Speaker: Doctor V. Castiglione (Pisa, IT)

Lifetime physical and athletic activity as novel risk factors in the development of wild-type transthyretin amyloid cardiomyopathy - a multicenter cohort study

Speaker: Doctor N. Schwegel (Graz, AT)

A review of routine bone scintigraphy reports for identification of incidental myocardial tracer uptake indicating cardiac amyloidosis

Speaker: Mr D. Hutt (London, GB)

Access the full session

Shedding light on transthyretin cardiac amyloidosis

Speakers: Doctor R. Amador, Doctor M. Pereira Santos, Mrs P. Lujan Garcia, Doctor V. Castiglione, Doctor N. Schwegel...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources